We retrospectively studied anthropometric and laboratory parameters (including serum triglycerides, cholesterol), as well as comedication in 504 patients diagnosed with prostate cancer between January 1997 and August 2002 at a single referral center, and compared these patients with 565 age-matched patients with benign prostatic hyperplasia. A positive correlation was found between serum triglycerides and prostate cancer (odds ratio: 1.148/mmol/l; 95% confidence interval (CI) 1.003-1.315; Po0.05) after correcting for age, body mass index, diabetes and comedication with statins. Hypertriglyceridemia may increase the risk of prostate cancer, and the prognostic relevancy of serum triglycerides should be studied prospectively.
Introduction
Prostate cancer (PC) is the most common cancer and the second leading cause of cancer deaths among North American men. 1 Benign prostatic hyperplasia (BPH) is a frequent condition, affecting about one-third of men in their 60s. 2 Both conditions are determined by a complex interaction of endogenous and exogenous factors. Higher age, the presence of androgens, a positive family history and black race are well-accepted risk factors for PC. Furthermore, a series of epidemiologic and laboratory observations suggest that both endogenous and exogenous antioxidants play an important and interdependent role in prostate carcinogenesis. 3, 4 While the presence of androgens is a precondition for prostate carcinogenesis, correlations are complex and some data suggest 5a-reductase activity and intraprostatic dihydrotestosterone to be potential contributors to the development of PC rather than systemic androgens. 5 Besides interethnic variability of the genetic make-up, diet may be a crucial exogenous factor explaining the marked international variability of incidence and mortality from PC. 6 The hypothesis that dietary fat as a major substrate for oxidative stress might be related to PC was initially suggested by international studies, which showed a strong positive correlation between PC mortality and per capita intake of fat, meat and milk. 7 Saturated fat intake in particular has been found to be positively associated with PC in some studies, 8, 9 but not all. 10 Moreover, no association has been found between unsaturated fat intake and the incidence of PC. 8, 10 Two studies have included prediagnostic plasma concentrations of specific fatty acids with relation to the incidence of PC. 11, 12 The US study found that reduced plasma concentrations of alinolenic acid (from animal fat) appeared to be associated with a reduced risk of PC (P ¼ 0.03), although no linear dose-response relationship was seen between PC and alinolenic acid levels. 11 The Norwegian study found a positive association between a-linolenic acid and PC risk and an inverse association between the ratio of linoleic (from non-animal fat) to a-linolenic acid and PC. 12 Cholesterol has also been examined in dietary studies, and a positive association with PC was reported in two case-control studies that did not adjust for energy intake, 13, 14 whereas no such correlation was found in a Swedish study that did adjust for energy intake. 15 Overall, there is a high degree of consistency with regard to consumption of animal fat, particularly red meat, and PC. The general pitfalls of retrospective studies on dietary fat intake and PC are dietary recall information and the critical adjustment for total energy intake, which has been shown to be itself associated with PC. 15 As dietary fat intake is highly correlated with energy intake in most Western populations, any correlation with fat intake may actually represent correlations with caloric intake in the absence of energy adjustments. Furthermore, a high-meat/high-fat diet entails a lower intake of plant foods containing protective factors such as lycopene, and a greater exposure to other food constituents that may promote prostate carcinogenesis, including polycyclic aromatic hydrocarbons and heterocyclic amines.
Data on the influence of obesity on PC are controversial. [16] [17] [18] [19] Three large recent studies found modest (9-27%) but statistically significant increases of PC incidence among obese (BMIX30 kg/m 2 ) men. 16, 17, 19 A recent review summarised available data to conclude that PC is likely to be obesity related. 20 In addition, there is evidence that obesity is associated with an increased risk of advanced PC or death from PC. 21 With regard to BPH, no correlation was found between total caloric or fat intake, BMI, diabetes and BPH in 1709 healthy aging men. 2 This was confirmed in a later study that found no association between energyadjusted total fat intake and BPH in 33 344 healthy aging men. 22 Studies comparing anthropometric and biochemical covariates in patients with PC and BPH, respectively, are limited. Metabolic parameters including fasting plasma glucose, lipid profile and clinical parameters such as BMI and waist-to-hip ratio were similar in patients with PC and BPH in a recent study. 23 Our primary hypothesis was that elevated blood lipids were positively correlated with PC as compared to patients with BPH. Our secondary hypothesis was that the individual BMI as an anthropometric surrogate for increased caloric and fat intake is positively correlated with PC. Varying results in studies comparing diet patterns and PC may be attributed to difficulties in the proper recording of dietary data, or reflect the complex relationship between fat intake and the development of PC. Despite the scarceness of data in the literature, there are some data suggesting plasma lipids to be a better surrogate parameter for the development of PC as compared to dietary fat intake, such as the study by Gann et al 11 , showing discrepancies between oral animal fat intake, individual plasma fatty acids and the development of PC. It seems intriguing to suggest individual genetic factors to play a potential role in determining blood and tissue lipid concentrations. As various intracellular signaling pathways that respond to circulating lipids begin to be unravelled, 20 as is their ability to modulate metabolic responses, it will be essential to increase our knowledge on the interrelationship between blood lipids and PC.
Materials and methods

Study population
All consecutive patients diagnosed with PC (according to ICD-C61) or BPH (ICD-N40) presenting at the Department of Urology of the Kantonsspital St Gallen (Switzerland) from January 1997 to August 2002 were included in a retrospective case-control study. PC was assessed according to the TNM-classification. Since we wanted to determine whether there was a causal relationship between lipid levels during carcinogenesis, and not that the state of disease was to alter lipid levels, the earliest available measurements of serum triglyceride and cholesterol concentrations were used for data analysis, that is, at a maximum of 10 y prior to the diagnosis of PC or BPH, respectively. Only if serum triglycerides or cholesterol were not assessed prior to diagnosis, blood lipid concentrations up to 5 y after diagnosis were used for data analysis. Although plasma lipid analysis is generally performed in the fasting state, we were unable to assess patient compliance and whether blood samples were drawn after a sufficient fasting period. Patient weight and length were assessed from patient files as early as 1 y prior to and as late as 1 y after diagnosis, and BMI (weight in kilograms divided by the square of height in meters) was calculated accordingly. Additional clinical and laboratory parameters assessed include serum creatinine, serum bilirubin, acute phase reaction, total protein, patient age, the diagnosis of diabetes and comedication with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (subsequently referred to as 'statins'). Comedication with statins was assumed if treatment with statins was documented within a 1-y interval from the time of cholesterol measurement. Serum prostate-specific antigen (PSA) was assessed in all patients. Potential confounders on serum lipids were taken as close to the original cholesterol determination as possible, but at most within a 6-month time interval. Patients were defined as diabetic individuals irrespective of whether the diagnosis of diabetes was made prior to or after the diagnosis of PC or BPH, in order to account for the prediagnostic condition of a metabolic syndrome.
Data analysis
Statistical analysis was performed using the statistical package SAS for Windows, Version 8e (SAS-institute, Cary, NC 27513, USA). Given the large number of observations, we relied on the central limit theorem and used the Student's t-test for continuous variables and the Fisher's exact test for categorical variables for univariate comparison of the differences between cases and controls. Patients with BPH served as the control group throughout data analysis. Odds ratios (OR) and 95% confidence intervals (CI) were estimated for the association between PC and the various patient characteristics including serum cholesterol, triglycerides, age, BMI, diabetes and the use of statins using logistic regression. Potential confounders including age, diabetes and BMI were included in the final model in the light of literature data. For the graphical display of the doseeffect of serum triglycerides on PC, the sample was divided into four equally spaced triglyceride groups, as Hypertriglyceridemia as a possible risk factor L Wuermli et al close to the quartiles as possible: o1.0, 1.0-1.4, 1.5-1.9, X2.0 mmol/l. A final bootstrap procedure using 1000 random samples from the original data set was performed for internal data validation. 
Results
Study population
A total of 1082 patients with either PC (n ¼ 504) or BPH (n ¼ 565) were included into the data analysis from January 1997 until August 2002. In all, 13 patients were excluded due to incorrect ICD-coding or missing patient files. Serum cholesterol was missing in 179
Data analysis
Age distribution was similar in patients with PC (cases) and BPH (controls) (Figure 1 ). Using univariate analysis, mean serum triglyceride concentrations were significantly higher in cases than in controls (1.9 vs 1.6 mmol/l; P ¼ 0.02) ( Table 1) . Mean PSA values were significantly higher in cases (118.4 mg/l) than in controls (3.5 mg/l) (Po0.0001). No other covariate differed significantly between patients and controls. After correction for age, BMI, diabetes and lipid-lowering drugs, the OR for the presence of PC was 1.148 per 1 mmol/l increase of serum triglycerides (95% CI 1.003-1.315; Po0.05, Table 2 ). No other covariate was significantly associated with PC in the multivariate analysis. A significant association was maintained even after log-transformation of triglycerides as well as in the validating boot-strap procedure. If patients were divided into four equally spaced and almost equally sized triglyceride subgroups (o1.0, 1.0-1.4, 1.5-2.0, 42.0 mmol/l), a dose-effect relationship seems plausible in the lower 'dose-range' (Figure 2) . If the analysis was limited to patients for whom prediagnostic lipid measurements were available, the association between higher triglyceride levels and PC remained similar but was no longer significant given the loss of power due to a smaller sample size. In the whole study population, a 1-y increase in patient age was associated with a significant decrease of serum triglycerides by 0.028 mmol/l (Po0.0001), and a one-point increase in BMI was associated with a significant 0.047 mmol/l increase of serum triglycerides (P ¼ 0.0002). Similarly, serum cholesterol showed a significant negative association with patient age (0.026 mmol/l per year; Po0.0001). Serum cholesterol was not included into the final multivariate analysis because of a high degree of collinearity with triglycerides and the lack of a significant association with the main study outcome ( Table 2 ). 
Discussion
We initiated this study based on the hypothesis that elevated blood lipids (triglycerides and/or cholesterol) may play an important role in the development of PC.
Patients with PC were retrospectively analyzed and compared with age-matched urologic patients with BPH. A significant positive correlation was found between serum triglycerides and PC, while no association was found for serum cholesterol or BMI. The association between increased serum triglycerides and the development of PC remained significant after correction for potential confounders such as patient age, diabetes, BMI and the use of lipid-lowering drugs. The two study groups were well matched and the correlation between serum triglycerides and the development of PC resisted 1000 bootstrap runs as internal validation. A missed diagnosis of PC in control patients remains of some concern. Mean PSA-value in the control group (3.5 mg/l), however, is in agreement with literature data, with regard to the higher mean patient age in our study. 24 So far, clinical studies have repeatedly shown a positive correlation between increased dietary fat intake or specific fatty foods and a higher incidence of PC, with some studies showing a greater than threefold increased incidence. 8, 9, 25 A conclusive mechanism by which fat acts as a promoter of prostate carcinogenesis has not been established, but a promotional effect of dietary fat in prostatic tissue comparable to testosterone has been suggested by animal studies. 26 In general, dietary studies suffer from certain limitations, including inadequacies of the dietary questionnaire methodology, 27 problems with analyzing dietary fatty acid components as well as the impact of food processing, 27 and the fact that interindividual variability of bioabsorption and lipid metabolism are not taken into account. On the other hand, data on the association between serum lipids and the development of PC are very limited. 11, 12 A significantly higher incidence of PC was found for men in successively higher quartiles of plasma a-linolenic acid levels (essential polyunsaturated fatty acid), after adjustment for various confounders (P trend ¼ 0.03), within a group of 14 916 US physicians. 11 The effect estimates were not significantly altered by adjustment for exercise, BMI, meat and dairy consumption or other fatty acid plasma levels (including linoleic acid). Additionally, the study found that the association of a-linolenic acid levels with PC was greater among men with low linoleic acid plasma levels and a reduced meat consumption, pointing to a complex interrelationship between food intake, plasma lipid levels and the development of PC. The authors concluded that low plasma levels of a-linolenic acid might be associated with a reduced incidence of PC, independently of high meat intake.
11
The results of the US study were later supported by a Norwegian case-control study which found a positive association between palmitoleic, palmitic and a-linolenic acid and the development of PC. 12 At the same time, an inverse association was found for increasing levels of tetracosanoic acid, the ratios of linoleic to a-linolenic acid and arachidonic to eicosapentaenoic acid and the development of PC. A third study using prediagnostic serum concentrations of a-linolenic acid did not find any significant correlation with PC. 28 Studies of blood concentrations of fatty acids also suffer from limitations, most importantly errors in identification and measurement of, for example, low a-linolenic acid plasma concentrations. 11, 27 Furthermore, the relationship between plasma fatty acid concentrations and corresponding intraprostatic levels has not been established. From a more generalistic point of view, it seems rather doubtful that a-linolenic acid, an important nutrient associated with decreased incidence of cardiovascular disease, is associated with an increased incidence of PC. 27 While the value of plasma fatty acids as surrogate markers for PC remains unclear, studies on the interrelationship between serum triglyceride and cholesterol levels and the development of PC may represent a valuable alternative.
Concerning cholesterol, the lack of a correlation with PC has to be seen on the background of controversial literature data. [13] [14] [15] Whereas increased intraprostatic cholesterol levels have been associated with malignancy, 29 cholesterol increases in tumor tissue likely occur by complex mechanisms that are inadequately mirrored by serum cholesterol. Furthermore, we found no association between BMI and the development of PC. This lack of correlation could be attributed to the fact that obesity is a reflection of net energy balance rather than fat intake. However, three large recent studies found modest (9-27%), but significant, increases in the incidence of PC among obese men (BMIX30 kg/m 2 ). 16, 17, 19 Caution is advised when drawing conclusions from our study, mainly because of the heterogeneity of the patient groups, missing cholesterol and triglyceride data points and the retrospective nature of the analysis. Nonetheless, our results provide some evidence that serum lipid levels may be useful surrogate markers for the development of PC.
In conclusion, we found a significant positive correlation between serum triglycerides and the development of PC in a group of newly diagnosed patients as compared to age-matched patients with BPH. To validate the usefulness of serum triglycerides as a surrogate marker for PC, prospective studies comparing dietary fat intake, plasma lipid levels, PC incidence and possibly genetic markers involved in fatty acid metabolism are necessary. Hypertriglyceridemia as a possible risk factor L Wuermli et al
